Report copyright - 17th ESO-ESMO Masterclass Clinical Oncology · • Benefit of bevacizumab added to first line chemotherapy in non-squamous cell carcinoma Sandler, JCO 2006; ... 17th ESO-ESMO Masterclass
Please pass captcha verification before submit form